The accounting treatment of invoice financing is a topic that raises questions among both business owners and accountants. How is a financed invoice recorded on the balance sheet? Is invoice financing debt or not? How is the financing fee treated in the income statement? In this guide, we walk through the journal entries, balance sheet treatment, and reporting of invoice financing in a practical manner. The guide is intended both for business owners who want to understand the impact of financing on financial statements and for accountants and financial management professionals who handle the practical entries.
The accounting principle: recourse is the deciding factor
The core issue in the accounting treatment of invoice financing is the recourse right – that is, who bears the credit risk. In non-recourse factoring, the financing company bears the credit risk: if the buyer does not pay, the company does not have to return the funds received. In this model, the trade receivable is fully derecognized from the company's balance sheet. In recourse factoring, the credit risk remains with the company: if the buyer does not pay, the company must reimburse the financing company. In this model, the trade receivable remains on the balance sheet and the financing is recorded as a liability.
The practical significance is considerable. In non-recourse financing, the company's balance sheet becomes lighter, the debt-to-equity ratio does not increase, and financial ratios improve. In recourse financing, both a trade receivable (assets) and a financing liability (liabilities) appear on the balance sheet, expanding the balance sheet and increasing the debt ratio. This can affect, for example, covenants in bank loan agreements or the business owner's ability to obtain other financing.
Non-recourse financing: journal entries in practice
In non-recourse invoice financing, the journal entries are more straightforward. When the company sends a EUR 10,000 invoice to a customer and assigns it to the financing company, the following occurs: the financing company pays an advance of 90 percent, i.e., EUR 9,000, to the company's account. The company derecognizes the trade receivable from the balance sheet (credit Trade Receivables EUR 10,000), records the advance received to the bank account (debit Bank Account EUR 9,000), and records the financing fee as an expense (debit Financing Costs EUR 200). The remaining EUR 800 (10,000 – 9,000 – 200) is remitted when the buyer pays the invoice.
Non-recourse financing journal entries (example: EUR 10,000 invoice, 90% advance, 2% fee):
- At the time of assignment: Debit Bank Account EUR 9,000, Debit Financing Costs EUR 200, Debit Prepaid Income EUR 800, Credit Trade Receivables EUR 10,000
- Upon final remittance: Debit Bank Account EUR 800, Credit Prepaid Income EUR 800
- The trade receivable is fully derecognized from the balance sheet at the time of assignment
- The financing fee of EUR 200 is recorded as financing costs in the income statement
- Net balance sheet impact: trade receivables decrease by EUR 10,000, cash increases by EUR 9,800 (net)
Recourse financing: journal entries in practice
In recourse financing, the journal entries are more complex because the trade receivable remains on the balance sheet and the advance received from the financing company is recorded as a liability. Using the same EUR 10,000 invoice: the financing company pays EUR 9,000 as an advance. The company records the advance to the bank account (debit Bank Account EUR 9,000) and records a short-term financing liability on the other side (credit Short-term Financing Liability EUR 9,000). The trade receivable of EUR 10,000 remains on the balance sheet. When the buyer pays the invoice, the financing liability is reversed and the remaining amount is remitted.
Recourse financing journal entries (example: EUR 10,000 invoice, 90% advance, 2% fee):
- Upon advance payment: Debit Bank Account EUR 9,000, Credit Short-term Financing Liability EUR 9,000
- Trade receivable of EUR 10,000 remains on the balance sheet unchanged
- When buyer pays: Debit Short-term Financing Liability EUR 9,000, Debit Financing Costs EUR 200, Credit Trade Receivables EUR 10,000, Debit Bank Account EUR 800
- The financing fee is recorded as an expense only upon final settlement
- Balance sheet impact: both assets (trade receivables) and liabilities (financing liability) increase – the balance sheet expands
Practical rule of thumb for accountants: if the contract includes a recourse right (right of recourse), the trade receivable stays on the balance sheet and the advance is recorded as a liability. If there is no recourse right, the trade receivable is derecognized at the time of assignment. Always check the contract terms before making journal entries.
Invoice financing
Learn how invoice financing works in practice before diving into accounting details
FAS vs IFRS – key differences
In Finnish accounting (FAS, Finnish Accounting Standards), the treatment of invoice financing is based on the general principles of the Accounting Act and the guidance of the Accounting Board (KILA). FAS is more flexible than IFRS and allows derecognition of trade receivables from the balance sheet more easily when the contract is non-recourse and the actual credit risk has transferred to the financing company. SMEs predominantly follow FAS, so the treatment of non-recourse invoice financing is straightforward.
In IFRS financial statements (particularly IFRS 9 Financial Instruments), derecognition of trade receivables requires a stricter assessment. Under IFRS 9, financial assets can only be derecognized if substantially all risks and rewards of ownership have been transferred. This means that even being non-recourse is not always sufficient – factors such as repurchase rights, late payment compensation liabilities, and other contract terms must also be evaluated. In practice, under IFRS, invoice financing more often remains on the balance sheet than under FAS.
Notes and the auditor's perspective
Significant financing arrangements must be described in the notes to the financial statements regardless of whether they appear on the balance sheet. The notes should disclose the nature and extent of the financing arrangement, the length of the contract period, whether it is recourse or non-recourse financing, the total amount of financed receivables on the balance sheet at the reporting date, and any off-balance sheet liabilities. Auditors pay particular attention to this, as the correct treatment of financing arrangements affects the true and fair view provided by the financial statements.
The practical recommendation is to communicate the terms of the financing arrangement to the auditor openly and as early as possible – preferably before signing the contract. This allows the accounting treatment to be agreed upon in advance and avoids unpleasant surprises during the financial statement phase. The auditor will want to see the financing agreement, understand the recourse terms, and assess whether the recording method is consistent with the contract terms.
Impact on the company's financial ratios
The accounting treatment of invoice financing directly affects the company's key financial ratios. In non-recourse financing, the accounts receivable turnover period shortens because financed receivables are derecognized from the balance sheet. This improves ROA (return on assets), the current ratio, and the quick ratio. The debt-to-equity ratio (gearing) does not change because the financing is not debt. In recourse financing, the situation is the opposite: the balance sheet expands, the debt ratio increases, and the equity ratio may weaken.
Financial ratio impacts are particularly important to consider if the company has bank loans with covenant conditions. Many covenant agreements set threshold values for the debt-to-equity ratio or equity ratio. Recording recourse financing as debt can breach covenants even though the company's actual financial position has not changed. In such situations, non-recourse financing is often the better option – or the matter should be discussed with the bank in advance.
Summary
The accounting treatment of invoice financing depends primarily on recourse rights. In non-recourse financing, the trade receivable is derecognized from the balance sheet and the financing fee is recorded as an expense – the balance sheet becomes lighter and financial ratios improve. In recourse financing, the trade receivable remains on the balance sheet and the advance is recorded as a liability – the balance sheet expands and the debt ratio increases. FAS financial statements offer more flexibility than IFRS. Significant financing arrangements are always described in the notes. Communicate with your auditor openly and early.
📌 Summary
The accounting treatment of invoice financing depends on recourse rights. Non-recourse financing derecognizes the trade receivable from the balance sheet and lightens it. Recourse financing is recorded as a liability and expands the balance sheet. FAS is more flexible than IFRS in the derecognition assessment. Financing arrangements must always be disclosed in the notes.
Our services
Transparent invoice financing services for SMEs
